This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, C.-M.
Right arrow Articles by Liaw, Y.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, C.-M.
Right arrow Articles by Liaw, Y.-F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2002, p. 16-21, Vol. 40, No. 1
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.1.16-21.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion

Chia-Ming Chu,* Chau-Ting Yeh, Ching-Song Lee, I-Shyan Sheen, and Yun-Fan Liaw

Liver Research Unit, Chang Gung Memorial Hospital, Chang Gung University, Taipei, Taiwan

Received 2 February 2001/ Returned for modification 15 May 2001/ Accepted 11 October 2001

This study aimed to investigate the ratios of precore stop mutant (codon 28; TGG to TAG) to total viremia in 53 HBeAg-positive patients with chronic hepatitis B by amplification-created restriction site assays along the course of HBeAg-to-anti-HBe seroconversion. At baseline, 11% had exclusive wild-type hepatitis B virus (HBV), 15% had exclusively precore mutant, and 74% had mixed viral strains. Precore mutant ratios correlated little with age, sex, or HBV DNA levels (all P > 0.1), but correlated modestly with alanine aminotransferase (ALT) levels (P = 0.05). The intervals from presentation to anti-HBe seroconversion correlated significantly with ALT and precore mutant ratios in univariate analysis but with only precore mutant ratios in multivariate analysis (P = 0.003). Precore mutant ratios at baseline were significantly higher (P < 0.001) in six patients with persistent high viremia and ALT elevation after anti-HBe seroconversion (group 1) than in 47 with remission (group 2). All group 1 patients had exclusive precore mutant after anti-HBe seroconversion, as did only 14 (30%) of the group 2 patients (P = 0.003). Among group 2 patients, precore mutant ratios at baseline or after anti-HBe seroconversion showed no significant difference between 34 patients with sustained remission and 13 with relapse. Cirrhosis developed in 50% (5 of 10) of patients with precore mutant ratios >50% at baseline but only in 12% (5 of 43) of those with precore mutant ratios of <50% at baseline (P < 0.05). In conclusion, precore mutant of variable ratios was frequently detected in HBeAg-positive patients with chronic hepatitis B. Precore mutant ratios tended to correlate with ALT levels and anti-HBe seroconversion, but high precore mutant ratios were associated with persistent hepatitis after anti-HBe seroconversion and increased risk of cirrhosis.

* Corresponding author. Mailing address: Liver Research Unit, Chang Gung Memorial Hospital, 199, Tung Hwa North Rd., Taipei 105, Taiwan. Phone: 886-3-3281200, ext. 8108. Fax: 886-3-3272236. E-mail: chu0066{at}cgmh.org.tw.

Journal of Clinical Microbiology, January 2002, p. 16-21, Vol. 40, No. 1
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.1.16-21.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Frelin, L., Wahlstrom, T., Tucker, A. E., Jones, J., Hughes, J., Lee, B. O., Billaud, J.-N., Peters, C., Whitacre, D., Peterson, D., Milich, D. R. (2009). A Mechanism To Explain the Selection of the Hepatitis e Antigen-Negative Mutant during Chronic Hepatitis B Virus Infection. J. Virol. 83: 1379-1392 [Abstract] [Full Text]  
  • Shinkai, N., Tanaka, Y., Ito, K., Mukaide, M., Hasegawa, I., Asahina, Y., Izumi, N., Yatsuhashi, H., Orito, E., Joh, T., Mizokami, M. (2007). Influence of Hepatitis B Virus X and Core Promoter Mutations on Hepatocellular Carcinoma among Patients Infected with Subgenotype C2. J. Clin. Microbiol. 45: 3191-3197 [Abstract] [Full Text]  
  • Chen, C.-H., Lee, C.-M., Lu, S.-N., Changchien, C.-S., Eng, H.-L., Huang, C.-M., Wang, J.-H., Hung, C.-H., Hu, T.-H. (2005). Clinical Significance of Hepatitis B Virus (HBV) Genotypes and Precore and Core Promoter Mutations Affecting HBV e Antigen Expression in Taiwan. J. Clin. Microbiol. 43: 6000-6006 [Abstract] [Full Text]  
  • Chen, M., Sallberg, M., Hughes, J., Jones, J., Guidotti, L. G., Chisari, F. V., Billaud, J.-N., Milich, D. R. (2005). Immune Tolerance Split between Hepatitis B Virus Precore and Core Proteins. J. Virol. 79: 3016-3027 [Abstract] [Full Text]  
  • Waltz, T. L., Marras, S., Rochford, G., Nolan, J., Lee, E., Melegari, M., Pollack, H. (2005). Development of a Molecular-Beacon Assay To Detect the G1896A Precore Mutation in Hepatitis B Virus-Infected Individuals. J. Clin. Microbiol. 43: 254-258 [Abstract] [Full Text]  
  • Franca, P. H. C., Gonzalez, J. E., Munne, M. S., Brandao, L. H., Gouvea, V. S., Sablon, E., Vanderborght, B. O. M. (2004). Strong Association between Genotype F and Hepatitis B Virus (HBV) e Antigen-Negative Variants among HBV-Infected Argentinean Blood Donors. J. Clin. Microbiol. 42: 5015-5021 [Abstract] [Full Text]  
  • Chen, M. T., Billaud, J.-N., Sallberg, M., Guidotti, L. G., Chisari, F. V., Jones, J., Hughes, J., Milich, D. R. (2004). A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc. Natl. Acad. Sci. USA 101: 14913-14918 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»